Project Number 5P50AG005138-29 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EPHB Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 3. Presenilin Biology a. Structure-Function Analysis Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator Georgakopoulos, Anastasios Principal Investigator First Name Anastasios Principal Investigator Last Name Georgakopoulos Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-10-002: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $224,101 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) Mount Siniai School of Medicine Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
